Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

businesswire.com
ABCL The article announces AbCellera's participation in upcoming investor conferences. This is a routine corporate event and does not inherently suggest positive or negative performance.

VANCOUVER, British Columbia--( BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:

A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.